Agoraphobia: Combined treatment and virtual reality. Preliminary results;Agorafobia: Tratamientos combinados y realidad virtual. Datos preliminares

Actas Espanolas de Psiquiatria

Volumn 36, Issue 2, 2008, Pages 94-101

  Pitti, Carmen T ^a,b   Penate W ^b   De La Fuente, J ^c   Bethencourt, J M ^b   Acosta, L ^b   Villaverde, M L ^b   Gracia, R ^a,b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Servicio Canario de la Salud Tenerife

Author keywords

Agoraphobia; Mixed treatments; Paroxetine; Venlafaxine; Virtual reality

Indexed keywords

CYCLOHEXANOL DERIVATIVE; PAROXETINE; VENLAFAXINE;

ADULT; AGORAPHOBIA; ARTICLE; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY;

ADULT; AGORAPHOBIA; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; PAROXETINE; THERAPY, COMPUTER-ASSISTED;

EID: 42549118674     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, et al. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr 2003;8(Suppl. 1):17-30.
2. Roy-Byrne PP, Wagner AW, Schraufnagel TJ. Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry 2005;66(Suppl. 4):16-22.
3. Starcevic V. Anxiety states: a review of conceptual and treatment issues. Curr Opin Psychiatry 2006;19:79-83.
4. Cloos JM. The treatment of panic disorder. Curr Opin Psychiatry 2005;18:45-50.
5. Sheehan DV, Burnham DB, Iyengar MK, Perera P. Paxil CR Panic Disorder Study Group. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder. J Clin Psychiatry 2005;66:34-40.
6. Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, et al. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety 2007;24:1-14.
7. Puigdermont D, Corripio I. Venlafaxina en el tratamiento de los trastornos de ansiedad. Actas Espaholas de Psiquiatria 2005;1: 21-8.
8. Thase ME. Treatment of anxiety disorders with venlafaxine XR. Expert Rev Neurother 2006;6:269-82.
9. Asociación Psiquiátrica Americana. Directrices para la práctica clínica en el tratamiento de pacientes con trastorno de angustia. Barcelona: Edika Med, 1999.
10. Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry 2005;66:28-32.
11. Bados A. Guía de tratamientos psicológicos eficaces para la agorafobia. En: Pérez M, Fernández JR, Fernández C, Amigo I, editores. Guía de tratamientos psicológicos eficaces I. Madrid: Pirámide, 2003; p. 247-70.
12. Furukawa TA, Watanabe N, Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006;188:305-12.
13. Mitte K. A meta-analysis of the efficacy of psycho and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005;88:27-45.
14. Peñate W, Pitti CT, Betheneourt JM, Gracia R. Agorafobia (con o sin pánico) y conductas de afrontamiento desadaptativas. Primera parte. Salud Mental 2006;29:22-9.
15. Echeburúa E, Corral P. Eficacia de las terapias psicológicas: de la investigación a la práctica clínica. Rev Intern Psicol Clin Salud 2001;1:181-201.
16. North M, North S. Virtual environments and psychological disorders. Electron J Virt Cult 1994;2:37-42.
17. Krijn M, Emmelkamp PMG, Olafsson RP, Biemond R. Virtual reality exposure therapy of anxiety disorders: a review. Clin Psychol Rev 2004;24:259-81.
18. Riva G. Virtual environments in clinical psychology. Psychother: Theor Res Pract Train 2003;40:68-76.
19. North M, North S, Coble J. Virtual Reality Therapy. Colorado: IPI Press, 1996.
20. Jang D, Ku J, Shin M, Choi Y, Kim S. Objective validation of the effectiveness of virtual reality psychotherapy. Cyberpsychology and Behavior 2000;3:369-74.
21. Choi YH, Vincelli F, Riva G, Wiederhold BK, Park KH. Effects of group experiential therapy for the treatment of panic disorder with agoraphobia. Cyberpsychol Behav 2005;8:387-93.
22. Vincelli F, Anolli L, Bouchard S, Wiederold BK, Zurloni V, Riva G. Experiential cognitive therapy in the treatment of panic disorders with agoraphobia: a controlled study. Cyberpsychol Behav 2003;6:321-8.
23. a Reunión Nacional Sobre las Fases Tempranas de las Enfermedades Mentales. Trastornos de Ansiedad. Santander, 2005.
24. Pitti CT, Peñate W, de la Fuente J, Betheneourt JM, Acosta L, Gracia R. El uso de la realidad virtual en el tratamiento combinado de la agorafobia. Un modelo de actuación. Congreso Nacional de Psiquiatría. Sevilla, 2006.
25. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
26. Echeburúa E, Corral P. La agorafobia: nuevas perspectivas de evaluación y tratamiento. Valencia: Promolibro, 1992.
27. Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984;52:1090-7.
28. Pitti CT, Peñate W, Betheneourt JM. Agorafobia (con o sin pánico) y conductas de afrontamiento desadaptativas. Estudio empirico. Segunda parte. Salud Mental 2006;29:24-33.
29. Beck A, Brown G, Epstein N, Steer T. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-7.
30. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory-II. San Antonio, Texas: Psychological Corporation, 1996.
31. Glantz K, Rizzo A, Graap K. Virtual reality for psychotherapy: current reality and future possibilities. Psychother Theor Res, Pract, Train 2003;40:55-67.